{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:53:07Z","timestamp":1772117587214,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009552.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000}}],"reference-count":39,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009552.pub3","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T06:59:25Z","timestamp":1442905165000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2015","author":[{"given":"Leanne","family":"Cheyne","sequence":"first","affiliation":[{"name":"Bradford Teaching Hospitals NHS Foundation Trust; Respiratory Medicine; Duckworth Lane Bradford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie J","family":"Irvin-Sellers","sequence":"additional","affiliation":[{"name":"St Peter's Hospital; Respiratory Medicine; Chertsey Surrey UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"White","sequence":"additional","affiliation":[{"name":"York Teaching Hospital; Respiratory Medicine; Wigginton Rd York North Yorks UK YO31 8HE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009552.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1183\/09031936.03.00083703","article-title":"One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease","volume":"23","author":"Oostenbrink","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD009552.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease","volume":"55","author":"Noord","year":"2000","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD009552.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0004|cit4","unstructured":"205.251 SPIRIVA \u00ae - Pulmonary Disease, Chronic Obstructive (Clinical trial 205.251) http:\/\/trials.boehringer-ingelheim.com\/trial_results\/clinical_trials_overview\/205\/205_251.html"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0005|cit5","unstructured":"205.252 SPIRIVA \u00ae - Pulmonary Disease, Chronic Obstructive http:\/\/trials.boehringer-ingelheim.com\/trial_results\/clinical_trials_overview\/205\/205_252.html"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2007.08.009","article-title":"A randomized study of tiotropium Respimats Soft MistTM Inhaler vs. ipratropium pMDI in COPD","volume":"102","author":"Voshaar","year":"2008","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0007|cit7","first-page":"A1483","article-title":"Cardiovascular safety of nebulized glycopyrrolate (SUN-101) compared with tiotropium, ipratropium and placebo in patients with COPD","volume":"187","author":"Kerwin","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009552.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4046\/trd.2005.58.5.498","article-title":"A comparison of tiotropium 18mug, once daily and ipratropium 40mug, 4 times daily in a double-blind, double-dummy, efficacy and safety study in adults with chronic obstructive pulmonary disease","volume":"58","author":"Kim","year":"2005","journal-title":"Tuberculosis and Respiratory Diseases"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0009|cit9","unstructured":"NCT02172443 Comparison of 18 mcg of tiotropium inhalation capsules and atrovent metered dose inhaler (2 puffs of 20 mcg) in a double blind, double dummy, efficacy and safety study in adults with chronic obstructive pulmonary disease (COPD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02172443"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0010|cit10","unstructured":"NCT02172469 A comparison of 18 \u00b5g of tiotropium inhalation capsules and Atrovent\u00ae metered dose inhaler (2 puffs of 20 \u00b5g, 4 times daily) in a double-blind, double-dummy, efficacy and safety study in adults with chronic obstructive pulmonary disease (COPD) https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02172469"},{"issue":"6","key":"10.1002\/14651858.CD009552.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pupt.2009.08.006","article-title":"Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease","volume":"22","author":"Niewoehner","year":"2009","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"issue":"82","key":"10.1002\/14651858.CD009552.pub3-BIB0012|cit12","first-page":"40","article-title":"Tiotropium: 1-Yr studies versus placebo\/ipratropium","volume":"12","author":"Serby","year":"2002","journal-title":"European Respiratory Review"},{"issue":"14","key":"10.1002\/14651858.CD009552.pub3-BIB0013|cit13","first-page":"1119","article-title":"Study on efficacy and safety of tiotropium powder in patients with stable COPD","volume":"16","author":"Wang","year":"2007","journal-title":"Chinese Journal of New Drugs"},{"issue":"6","key":"10.1002\/14651858.CD009552.pub3-BIB0014|cit14","first-page":"363","article-title":"Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease","volume":"29","author":"Zheng","year":"2006","journal-title":"Chinese Journal of Tuberculosis and Respiratory Diseases"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1378\/chest.117.2_suppl.63S","article-title":"The pharmacological properties of tiotropium","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD009552.pub3-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002876.pub2","article-title":"Tiotropium for stable chronic obstructive pulmonary disease","author":"Barr","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0017|cit17","unstructured":"British National Formulary www.bnf.org"},{"issue":"1","key":"10.1002\/14651858.CD009552.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.09-0011","article-title":"Cardiovascular safety of tiotropium in patients with COPD","volume":"137","author":"Celli","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD009552.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/thoraxjnl-2012-201926","article-title":"Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials","volume":"68","author":"Dong","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0020|cit20","unstructured":"GOLD From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2015_Apr2.pdf"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0021|cit21","article-title":"Clearing the air: A national study of chronic obstructive pulmonary disease","volume-title":"Healthcare Commission","author":"Great Britain. Commission for Healthcare Audit and Inspection","year":"2006"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0022|cit22","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD009552.pub3-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009039","article-title":"The added effect of inhaled corticosteroids to tiotropium and long-acting beta2-agonists for chronic obstructive pulmonary disease","author":"Karner","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009552.pub3-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008532.pub2","article-title":"Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease","author":"Karner","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009552.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008989","article-title":"Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease","author":"Karner","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009552.pub3-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009285.pub2","article-title":"Tiotropium versus placebo for chronic obstructive pulmonary disease","author":"Karner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/COPD.S4802","article-title":"Tiotropium HandiHaler\u00ae in the treatment of COPD: A safety review","volume":"4","author":"Kesten","year":"2009","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0028|cit28","first-page":"75-76, 78","article-title":"Tiotropium as a controller of bronchoconstriction","volume":"16","author":"Lubinski","year":"2004","journal-title":"Polski Merkuriusz Lekarski"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0029|cit29","unstructured":"NICE Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update) https:\/\/www.nice.org.uk\/guidance\/cg101"},{"issue":"1","key":"10.1002\/14651858.CD009552.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1378\/chest.08-2367","article-title":"Cardiovascular events associated with ipratropium bromide in COPD","volume":"137","author":"Ogale","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD009552.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ebm.2011.100171","article-title":"Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo","volume":"16","author":"Ram","year":"2011","journal-title":"Evidence Based Medicine"},{"key":"10.1002\/14651858.CD009552.pub3-BIB0032|cit32","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"10","key":"10.1002\/14651858.CD009552.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1525-1497.2006.00507.x","article-title":"Meta-analysis: Anticholinergics, but not beta agonists, reduce severe exacerbations and respiratory mortality in COPD","volume":"21","author":"Salpeter","year":"2006","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009552.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1378\/chest.07-2919","article-title":"Long-acting bronchodilators in COPD","volume":"133","author":"Sears","year":"2008","journal-title":"Chest"},{"issue":"12","key":"10.1002\/14651858.CD009552.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD009552.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","article-title":"Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications","volume":"68","author":"Singh","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD009552.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007891.pub2","article-title":"Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease","author":"Welsh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"16","key":"10.1002\/14651858.CD009552.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium respimat inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009552.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4187\/respcare.00852","article-title":"Tiotropium for treatment of stable COPD: A meta-analysis of clinically relevant outcomes","volume":"56","author":"Yohannes","year":"2011","journal-title":"Respiratory Care"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009552.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T05:17:14Z","timestamp":1641878234000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009552.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009552.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725803989.793532736","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}